S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69

Masimo Stock Forecast, Price & News

-3.75 (-1.69%)
(As of 01/21/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
279,831 shs
Average Volume
366,824 shs
Market Capitalization
$12.03 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive MASI News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

Masimo logo

About Masimo

Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.


Masimo Co. (NASDAQ:MASI) Director Sells $137,220.00 in Stock
January 20, 2022 |  americanbankingnews.com
Masimo Co. (NASDAQ:MASI) Director Sells $150,006.00 in Stock
January 12, 2022 |  americanbankingnews.com
Masimo sees FY21 revenue growth of 8% - Seeking Alpha
January 12, 2022 |  seekingalpha.com
Masimo (NASDAQ:MASI) Updates FY21 Earnings Guidance
January 11, 2022 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Electromedical equipment
Health Care Equipment
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$1.14 billion
Cash Flow
$4.21 per share
Book Value
$25.47 per share


Net Income
$240.30 million
Pretax Margin




Free Float
Market Cap
$12.03 billion

Company Calendar

Last Earnings
Next Earnings (Confirmed)
Fiscal Year End

Social Links


Overall MarketRank

2.32 out of 5 stars

Medical Sector

266th out of 1,418 stocks

Electromedical Equipment Industry

6th out of 28 stocks

Analyst Opinion: 3.3Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -

Masimo (NASDAQ:MASI) Frequently Asked Questions

Is Masimo a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Masimo stock.
View analyst ratings for Masimo
or view top-rated stocks.

How has Masimo's stock price been impacted by Coronavirus (COVID-19)?

Masimo's stock was trading at $182.64 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MASI stock has increased by 19.3% and is now trading at $217.91.
View which stocks have been most impacted by COVID-19

When is Masimo's next earnings date?

Masimo is scheduled to release its next quarterly earnings announcement on Tuesday, February 15th 2022.
View our earnings forecast for Masimo

How can I listen to Masimo's earnings call?

Masimo will be holding an earnings conference call on Tuesday, February 15th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) released its earnings results on Monday, October, 25th. The medical equipment provider reported $0.94 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.91 by $0.03. The medical equipment provider had revenue of $307.40 million for the quarter, compared to analysts' expectations of $295.79 million. Masimo had a net margin of 19.23% and a trailing twelve-month return on equity of 15.56%. Masimo's quarterly revenue was up 10.5% on a year-over-year basis. During the same period last year, the business earned $0.80 EPS.
View Masimo's earnings history

What guidance has Masimo issued on next quarter's earnings?

Masimo issued an update on its FY22 earnings guidance on Tuesday, January, 11th. The company provided EPS guidance of $4.34 for the period, compared to the Thomson Reuters consensus estimate of $4.35. The company issued revenue guidance of $1.35 billion, compared to the consensus revenue estimate of $1.35 billion.

What price target have analysts set for MASI?

3 brokerages have issued 1-year price objectives for Masimo's shares. Their forecasts range from $285.00 to $330.00. On average, they anticipate Masimo's stock price to reach $308.33 in the next year. This suggests a possible upside of 41.5% from the stock's current price.
View analysts' price targets for Masimo
or view top-rated stocks among Wall Street analysts.

Who are Masimo's key executives?

Masimo's management team includes the following people:
  • Joe E. Kiani, Chairman & Chief Executive Officer
  • Bilal Muhsin, Chief Operating Officer
  • Micah Young, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
  • Yongsam Lee, Chief Information Officer & Executive VP
  • Anand Sampath, Executive VP-Operations & Clinical Research

What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo CEO Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among Masimo's employees.

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Who are Masimo's major shareholders?

Masimo's stock is owned by a number of institutional and retail investors. Top institutional investors include Vaughan Nelson Investment Management L.P. (1.35%), Retirement Systems of Alabama (0.28%), Baillie Gifford & Co. (0.16%), Scout Investments Inc. (0.12%), Forte Capital LLC ADV (0.08%) and State of Alaska Department of Revenue (0.06%). Company insiders that own Masimo stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Tao Levy, Thomas Samuel Mcclenahan and Yongsam Lee.
View institutional ownership trends for Masimo

Which major investors are selling Masimo stock?

MASI stock was sold by a variety of institutional investors in the last quarter, including Vaughan Nelson Investment Management L.P., Exchange Traded Concepts LLC, Scout Investments Inc., IBM Retirement Fund, Crossmark Global Holdings Inc., Diversified Trust Co, Spire Wealth Management, and Tributary Capital Management LLC. Company insiders that have sold Masimo company stock in the last year include Adam Mikkelson, Joe E Kiani, Micah W Young, and Tao Levy.
View insider buying and selling activity for Masimo
or view top insider-selling stocks.

Which major investors are buying Masimo stock?

MASI stock was acquired by a variety of institutional investors in the last quarter, including HighTower Trust Services LTA, Sciencast Management LP, Baillie Gifford & Co., State of Alaska Department of Revenue, Forte Capital LLC ADV, Nordea Investment Management AB, J2 Capital Management Inc, and Russell Investments Group Ltd..
View insider buying and selling activity for Masimo
or or view top insider-buying stocks.

How do I buy shares of Masimo?

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $217.91.

How much money does Masimo make?

Masimo has a market capitalization of $12.03 billion and generates $1.14 billion in revenue each year. The medical equipment provider earns $240.30 million in net income (profit) each year or $4.01 on an earnings per share basis.

How many employees does Masimo have?

Masimo employs 5,300 workers across the globe.

When was Masimo founded?

Masimo was founded in 1989.

What is Masimo's official website?

The official website for Masimo is www.masimo.com.

Where are Masimo's headquarters?

Masimo is headquartered at 52 DISCOVERY, IRVINE CA, 92618.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at (949) 297-7000, via email at [email protected], or via fax at 949-297-7001.

This page was last updated on 1/23/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.